“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  CVS

CVS HEALTH CORP

LISTEDNYSE
SYMBOLCVS
SIC5912
STATE OF INC.DE
FISCAL YEAR ENDSDecember 31
CIK64803

RETAIL-DRUG STORES AND PROPRIETARY STORES · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions-10001002003004005002016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share-2.000.002.004.006.008.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt64,57046.2
Stockholders' equity75,21453.8
Total capitalization139,784100.0

1,278,970,369 shares outstanding at 29 July 2026 (cover page of the 10-Q filed 5 August 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, noncurrent60,502
Current maturities4,068
Short-term borrowings / commercial paper0

CAPITAL STOCK 12/31/25

Common shares authorized3,200,000,000
Common shares issued1,787,000,000
Treasury shares516,000,000
Par or stated value per share ($)0.01
Preferred stock ($ millions)0
Outstanding at 7/29/261,278,970,369

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20252.66191.4
20242.6672.7
20232.4237.4
20222.2067.5
20212.0033.2

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware. Formerly known as CVS CAREMARK CORP (to 3 September 2014); CVS/CAREMARK CORP (to 8 May 2007); CVS CORP (to 22 March 2007); MELVILLE CORP (to 10 January 1997).

BUSINESS: Classified by the SEC under Standard Industrial Classification 5912, Retail-Drug Stores and Proprietary Stores. Large accelerated filer. Principal executive office: One Cvs Dr., Woonsocket, RI 02895. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues402,067372,809357,776
Cost of revenues221,167206,287217,098
Depreciation and amortization4,6064,5974,366
Operating income4,6608,51613,743
Interest expense3,1192,9582,658
Income before income taxes2,1366,14811,173
Income taxes4081,5622,805
Net income1,7684,6148,344
Earned per share, diluted ($)1.393.666.47
Dividends per share ($)2.662.662.42

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents8,4538,586
Receivables, net39,77936,469
Inventories19,24618,107
Total current assets74,71468,645
Property, plant and equipment, net13,08312,993
Goodwill85,47891,272
Total assets253,538253,215
Total current liabilities88,69284,609
Long-term debt60,50260,527
Total liabilities178,156177,485
Stockholders' equity75,21475,560
Total liabilities and equity253,538253,215

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/25402,0674,6601,7680.41.392.6610,6392,8327,807253,538178,15664,57075,2142.40.86
12/31/24372,8098,5164,6141.23.662.669,1072,7816,326253,215177,48566,27075,5606.10.88
12/31/23357,77613,7438,3442.36.472.4213,4263,03110,395249,728173,09261,61076,46110.90.81
12/31/22322,4677,9544,3111.33.262.2016,1772,72713,450228,275156,50652,25771,4696.00.73
12/31/21292,11113,3108,0012.76.022.0018,2652,52015,745232,999157,61856,17675,07510.70.75
12/31/20268,70613,9117,1792.75.462.0015,8652,43713,428230,715161,01464,64769,38910.30.93
12/31/19256,77611,9876,6342.65.082.0012,8482,45710,391222,449158,27968,48063,86410.41.07
12/31/18194,5794,021(594)-0.3(0.57)2.008,8652,0376,828196,456137,91374,14958,225-1.01.27
12/31/17184,7869,5386,6223.66.442.008,0071,9186,08995,13157,43628,27837,69117.60.75
12/31/16177,54610,3865,3173.04.901.7010,1412,2247,91794,46257,628d27,57436,83014.40.75

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

CVS HEALTH Corp
CIK 64803 · EIN 05-0494040

PRINCIPAL OFFICE:

One Cvs Dr., Woonsocket, RI 02895
Tel.: 4017651500

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

5912 · Retail-Drug Stores and Proprietary Stores

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 10 February 2026

FORMER NAMES:

CVS CAREMARK CORP; CVS/CAREMARK CORP; CVS CORP

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

8/17/268-Kperiod 8/13/26
8/5/2610-Qperiod 6/30/26
8/5/268-Kperiod 8/5/26
5/18/268-Kperiod 5/14/26
5/6/2610-Qperiod 3/31/26
5/6/268-Kperiod 5/6/26
4/3/26DEF 14Aperiod 5/14/26
3/19/268-Kperiod 3/18/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/10/26) · 10-K FY2024 (filed 2/12/25) · 10-K FY2023 (filed 2/7/24) · 10-K FY2022 (filed 2/8/23) · 10-K FY2021 (filed 2/9/22) · 10-K FY2020 (filed 2/16/21) · 10-K FY2019 (filed 2/18/20) · 10-K FY2018 (filed 2/28/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice